Skip to content
Screener

Rein Therapeutics Inc. RNTX Q1 2025 Annual earnings

Reported April 7, 2025 · Before market open

Revenue-
EPS-$0.26Miss by $0.12
EPS estimate-$0.14

Next report

Nov 13, 2026 (in 2 months)
EPS estimate-$0.10

Financials

Q1 2025

Income statement

See full
Revenue-—
Operating income-$5.6M+22.2%
Net income-$5.5M+22.7%
EPS (diluted)-$0.25+70.9%

Balance sheet

See full
Cash & equivalents$7.4M-38.3%
Total assets$57.6M-41.9%

Cash flow

See full
Operating cash flow-$6.2M-17.2%

FAQ

When did Rein Therapeutics Inc. report Q1 2025 earnings?
Rein Therapeutics Inc. (RNTX) reported Q1 2025 earnings on April 7, 2025 before market open.
What were Rein Therapeutics Inc.'s Q1 2025 revenue and EPS?
Rein Therapeutics Inc. reported revenue of - and eps of $-0.26 for Q1 2025.
Did Rein Therapeutics Inc. beat estimates in Q1 2025?
EPS missed the consensus estimate of $-0.14 by $0.12.
Where can I find Rein Therapeutics Inc.'s Q1 2025 SEC filings?
You can read the 10-K periodic report (0000950170-25-051566) directly on SEC EDGAR. The filing index links above go to sec.gov.